Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection

MLA

Ya-Nan Li, et al. “Inhibition of Myeloid-Derived Suppressor Cell Arginase-1 Production Enhances T-Cell-Based Immunotherapy against Cryptococcus Neoformans Infection.” Nature Communications, vol. 13, no. 1, July 2022, pp. 1–15. EBSCOhost, https://doi.org/10.1038/s41467-022-31723-4.

APA

Ya-Nan Li, Zhong-Wei Wang, Fan Li, Ling-Hong Zhou, Yan-Shan Jiang, Yao Yu, Hui-Hui Ma, Li-Ping Zhu, Jie-Ming Qu, & Xin-Ming Jia. (2022). Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection. Nature Communications, 13(1), 1–15. https://doi.org/10.1038/s41467-022-31723-4

Chicago

Ya-Nan Li, Zhong-Wei Wang, Fan Li, Ling-Hong Zhou, Yan-Shan Jiang, Yao Yu, Hui-Hui Ma, Li-Ping Zhu, Jie-Ming Qu, and Xin-Ming Jia. 2022. “Inhibition of Myeloid-Derived Suppressor Cell Arginase-1 Production Enhances T-Cell-Based Immunotherapy against Cryptococcus Neoformans Infection.” Nature Communications 13 (1): 1–15. doi:10.1038/s41467-022-31723-4.